526 filings
Page 3 of 27
8-K
QLGN
Qualigen Therapeutics Inc
20 Jan 23
Departure of Directors or Certain Officers
4:30pm
8-K
QLGN
Qualigen Therapeutics Inc
10 Jan 23
Regulation FD Disclosure
4:15pm
EFFECT
QLGN
Qualigen Therapeutics Inc
6 Jan 23
Notice of effectiveness
12:15am
UPLOAD
QLGN
Qualigen Therapeutics Inc
3 Jan 23
Letter from SEC
12:00am
CORRESP
QLGN
Qualigen Therapeutics Inc
3 Jan 23
Correspondence with SEC
12:00am
S-3
QLGN
Qualigen Therapeutics Inc
Shelf registration
30 Dec 22
4:31pm
8-K
QLGN
Qualigen Therapeutics Inc
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
8-K
QLGN
Qualigen Therapeutics Inc
12 Dec 22
Other Events
9:01am
8-K
QLGN
Qualigen Therapeutics Inc
22 Nov 22
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
9:10am
10-Q
2022 Q3
QLGN
Qualigen Therapeutics Inc
Quarterly report
14 Nov 22
4:53pm
8-K
QLGN
Qualigen Therapeutics Inc
28 Oct 22
Submission of Matters to a Vote of Security Holders
5:03pm
8-K
QLGN
Qualigen Therapeutics Inc
26 Oct 22
Regulation FD Disclosure
9:00am
DEFA14A
QLGN
Qualigen Therapeutics Inc
28 Sep 22
Additional proxy soliciting materials
4:05pm
8-K
QLGN
Qualigen Therapeutics Inc
2 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00am
8-K
QLGN
Qualigen Therapeutics Inc
26 Aug 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
QLGN
Qualigen Therapeutics Inc
16 Aug 22
Qualigen Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
6:20am
10-Q
2022 Q2
QLGN
Qualigen Therapeutics Inc
Quarterly report
15 Aug 22
4:17pm
EFFECT
QLGN
Qualigen Therapeutics Inc
8 Aug 22
Notice of effectiveness
12:15am
4
Wajdi Abdul-Ahad
4 Aug 22
Qualigen Therapeutics / Wajdi Abdul-Ahad ownership change
4:17pm
4
Christopher L. Lotz
4 Aug 22
Qualigen Therapeutics / Christopher L. Lotz ownership change
4:16pm